EATG » Immune response

Immune response

Treg cells protect babies from getting HIV infection from their mothers

June 10, 2018 – Atlanta, GA – Scientists now report that Treg cells, a type of regulatory lymphocyte, may be protecting babies in the womb from getting infected with the…

The rise of broadly neutralizing antibodies

Research on broadly neutralizing antibodies (bNAbs) is taking the field of HIV prevention science in new directions, with implications for new prevention interventions and vaccine development. There’s much to know…

Unlocking the secrets of HIV’s persistence

Thanks to advances in the development of anti-retroviral therapy (ART), patients with HIV are living longer than ever before. And yet, even in patients on very effective, long-term ART, HIV…

Different diseases elicit distinct sets of exhausted T cells

Epigenomics survey of human immune cells has implications for fighting chronic infections, autoimmunity, and cancer The battle between the human immune system and long-term, persisting infections and other chronic diseases…

Universal antibody drug for HIV-1 prevention and immunotherapy

A research team led by scientists at AIDS Institute and Department of Microbiology, Li Ka Shing Faculty of Medicine of The University of Hong Kong (HKU) invents a universal antibody…

Researcher finds link between crystal methamphetamine and immune changes in HIV

A researcher at the University of Miami Miller School of Medicine has found that the use of stimulants such as methamphetamine can negatively affect the health of HIV-positive people even…

HIV cell dysfunction discovery sheds light on how virus works

A new study has revealed that certain immune cells behave differently in HIV-infected patients than they do in healthy individuals. A team of chemical and biomedical engineers from the Cockrell…

CATIE: March/April 2018 issue of TreatmentUpdate now online

TreatmentUpdate is CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment. TreatmentUpdate 226: Inflammation, March/April 2018 issue is available at: http://www.catie.ca/en/treatmentupdate/treatmentupdate-226/inflammation

Integral Molecular’s protein engineering technology facilitates HIV vaccine development

PHILADELPHIA, March 13, 2018 - Integral Molecular, the industry leader in engineering membrane proteins, has extended its protein engineering capabilities to stabilize viral proteins and produce more effective candidate vaccines…

CATIE: February 2018 issue of TreatmentUpdate now online

TreatmentUpdate is CATIE’s flagship digest on cutting-edge developments in HIV and hepatitis C research and treatment. TreatmentUpdate 225: Inflammation, HIV and marijuana, February 2018 issue is available at: http://www.catie.ca/en/treatmentupdate/treatmentupdate-225/inflammation-hiv-and-marijuana